This marks a significant milestone as SIGX1094 is the first pipeline drug discovered using AI and organoid disease model to enter clinical trials, and the first targeted therapy candidate to ...

Organoid technology has lately risen to prominence as a critical tool for both basic and biomedical research. Embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and primary ...